Anlon Healthcare Ltd
Anlon Healthcare Ltd Share Price Today: Live Updates & Key Insights
Get insights on Anlon Healthcare Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Anlon Healthcare Ltd Share Price Chart
AHCL at 05 Nov 2026 02:00 PM Pharmaceuticals
27.99 +1.33(+4.99%)
Lowest Today 26.61
Highest Today 27.99
Today's Open 27.05
Prev. Close 26.66
52 Week High 172.75
52 Week Low 12.91
Anlon Healthcare Ltd Fundamentals
Traded Volume: 41,90,744
Market Cap(Cr): 1,487.71
Avg Traded Price 27.38
1 Year return %
Upper Circuit 28
Lower Circuit 26.6
P/E TTM 4.00
P/B Ratio 1.321
Traded Value(Cr) 1172.99
EPS TTM 6.712
Book value/Share 20.180
Dividend Yield 1Y 0.00%
Anlon Healthcare Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Anlon Healthcare Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Anlon Healthcare Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W +14.39%
1M -10.35%
3M +92.11%
1Y 0.00%
YTD +79.77%
Anlon Healthcare Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Anlon Healthcare Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 50.53L
Day Before Yesterday 58.30L
1W Avg 66.46L
1M Avg 84.56L
3M Avg 2.17Cr
Anlon Healthcare Ltd Technical Details
Anlon Healthcare Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 26
Support 2 24
Support 3 24
Pivot Point : 26
Resistance 1 27
Resistance 2 28
Resistance 3 29
Anlon Healthcare Ltd Corporate Actions
Anlon Healthcare Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Anlon Healthcare Ltd’s capital allocation strategies.
All
Ex-Date 24-Apr-2026 Type B Description share@1:1 Record Date 24-Apr-2026 Ratio 1:1
Ex-Date 24-Apr-2026 Type S Description share@1:5.00 Record Date 24-Apr-2026 Ratio 1:5.00
Dividends
No Dividend has been declared by AHCL
Bonus
Record Date 24-Apr-2026 Ex-Bonus Date 24-Apr-2026 Ratio 1:1
Splits
Record Date 24-Apr-2026 Split Date 24-Apr-2026 Face Value (Before/After) 10.00/2.00
Others
Rights No Rights has been declared by AHCL
Anlon Healthcare Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Anlon Healthcare Ltd with leading peers in the pharmaceuticals & biotechnology sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Anlon Healthcare Ltd's relative performance and valuation against major competitors.
Stock Name Gujarat Inject (Kerala) Ltd ₹11.14 (0.00%) M. Cap (Cr) 1.63 1 Yr Return (%) +354.69% P/E (TTM) 54.15 PB Ratio 13.68
Stock Name Smruthi Organics Ltd ₹137.65 (-1.89%) M. Cap (Cr) 1.58 1 Yr Return (%) +5.88% P/E (TTM) 22.58 PB Ratio 2.19
Stock Name Medico Remedies Ltd ₹18.48 (-0.43%) M. Cap (Cr) 1.53 1 Yr Return (%) -62.62% P/E (TTM) 11.09 PB Ratio 1.97
Stock Name Anlon Healthcare Ltd ₹27.99 (+4.99%) M. Cap (Cr) 14.88 1 Yr Return (%) NaN% P/E (TTM) 4.17 PB Ratio 0.76
Stock Name Quest Laboratories Ltd ₹84.55 (-3.37%) M. Cap (Cr) 1.39 1 Yr Return (%) -4.52% P/E (TTM) 9.23 PB Ratio 1.43
Stock Name Curis Lifesciences Ltd ₹177.00 (0.00%) M. Cap (Cr) 1.43 1 Yr Return (%) NaN% P/E (TTM) 20.69 PB Ratio 3.02
Stock Name Natural Capsules Ltd ₹143.99 (+4.51%) M. Cap (Cr) 1.50 1 Yr Return (%) -30.35% P/E (TTM) -6.96 PB Ratio 0.69
Anlon Healthcare Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Anlon Healthcare Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2026 -46.36 Mar 2025 -22.55
PARTICULARS Investing Activities Mar 2026 -27.96 Mar 2025 2.79
PARTICULARS Financing Activities Mar 2026 76.29 Mar 2025 18.94
PARTICULARS Net Cash Flow Mar 2026 1.96 Mar 2025 -0.82
Anlon Healthcare Ltd Shareholding Pattern
This shows the ownership breakdown of Anlon Healthcare Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 52.68%
Public 46.02%
Other Institutions 0.3%
FII 0.99%
Mutual Funds N/A%
About Anlon Healthcare Ltd
Anlon Healthcare Limited was originally incorporated as 'Anlon Ventures Private Limited', dated November 19, 2013 with the RoC. The Company changed the name to 'Anlon Healthcare Private Limited' dated May 27, 2015 issued by the RoC and further beame a Public Company named 'Anlon Healthcare Limited' dated September 2, 2024.ANLON an ideal API partner is research-driven company engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Bulk Drugs and advanced pharmaceutical intermediates. It specialize in manufacturing of high-purity pharmaceutical intermediates used as key starting materials for APIs and finished dosage formulations. It is among the few Indian manufacturers of products such as Loxoprofen Sodium Dihydrate, Ketoprofen, and Dexketoprofen Trometamol, which are widely used in pain management and anti-inflammatory therapies which comply with the regulatory requirements of leading health authorities such as FDA, PMDA, KFDA, cGMP, WHO-GMP. In addition to manufacturing of Pharma Intermediate and APIs in accordance with various domestic and international standards, the Company has recently started undertaking custom manufacturing services for complex or novel chemical compounds. The Company started commercial production of Pharma Intermediate and API in 2018. It work out manufacturing activities at Rajkot, Gujarat, which comprise of two separate manufacturing blocks for manufacturing of Pharmaceutical Intermediate and APIs respectively with an aggregate installed production capacity of 400 MTPA.The Company launched the Initial Public Offering of 1,33,00,000 equity shares having the face value of Rs 10, by raising funds aggregating to Rs 121.03 Cr via fresh issue on 29 August, 2025.The Company acquired 67.48% equity shareholding in Apiqo Organics Private Limited and become subsidiary of the company w.e.f. January 09, 2026. It further acquired 56.67% equity shareholding in Bizotic Life Science Private Limited and become subsidiary of the company w.e.f. March 20, 2026.
Chairman / Executive Director / M D / Promoter
Punitkumar R Rasadia
Registered office 101/102 Silvercoin Complex Opp, Crystal Mall Kalawad Road, Rajkot, Gujarat, 360005
FAX :+91 281 2562538/39
Background
Incorporation Year 2013
Face Value ₹2.00
Market Lot 1
FAQs on Anlon Healthcare Ltd
How to buy Anlon Healthcare Ltd shares?
To buy Anlon Healthcare Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the market cap of Anlon Healthcare Ltd?
The company has a market capitalization of ₹1,487.71.
What is the PE & PB ratio of Anlon Healthcare Ltd?
PE is 4 and PB is 1.321.
What is the Anlon Healthcare Ltd dividend for 2025–26?
For the 2025–26 financial year, Anlon Healthcare Ltd declared a final dividend of 0.00% per share.